SIRT7 and metastatic neoplasm: High SIRT7 expression is associated with aggressive cancer phenotypes, metastatic diseases and poor patient prognosis; down-regulating SIRT7 reverses the metastatic properties of epithelial and mesenchymal cancer cells.